Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intervacc AB | 6,465,011 | net | 21 Feb 2025 | tx 1+6,465,011 |
| Asker Healthcare Group | 403,103 | net | 31 Mar 2025 | tx 3+1,189,114−786,011 |
| Swedish Orphan Biovitrum AB (publ) | 79,745 | net | 18 Jul 2019 | tx 1+79,745 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2025 | OTHER | Asker Healthcare Group | 400,000 | 0.00 SEK | |
| 31 Mar 2025 | OTHER | Asker Healthcare Group | 789,114 | 0.00 SEK | |
| 26 Mar 2025 | SALE | Asker Healthcare Group | 786,011 | 70.00 SEK | |
| 21 Feb 2025 | GRANT_AWARD | Intervacc AB | 6,465,011 | 0.85 SEK | |
| 18 Jul 2019 | PURCHASE | Swedish Orphan Biovitrum AB (publ) | 79,745 | 50.16 SEK | deriv |